The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
Common and highly contagious illnesses are reaching several-month highs. Norovirus has almost reached a several-year record.
RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...
The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...
Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...
Mask requirements and visitor restrictions have been implemented at OSF HealthCare hospitals to help slow the spread of respiratory illnesses.
The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...
Background: Research from multiple regions indicates that Coronavirus disease of 2019 pandemic has altered the ...
Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...